MicroRNA expression changes in Parkinson's disease (PD) patients' leukocytes prior to and following deep brain...

Area of Science:

• Neuroscience
• Genetics
• Biomarkers

Background:

• Parkinson's disease (PD) is a leading neurodegenerative disorder in the elderly, with complex etiology and no current disease-modifying treatments.
• The role of microRNAs (miRNAs) in PD pathogenesis remains largely undetermined, necessitating further investigation into disease mechanisms and therapeutic strategies.

Purpose of the Study:

• To investigate the expression profiles of approximately 900 miRNAs in Parkinson's disease patients.
• To compare miRNA expression before and after deep brain stimulation (DBS) therapy, including on and off stimulation states.
• To identify potential miRNA biomarkers for PD by comparing patient samples with age and gender-matched healthy controls (HC).

Main Methods:

• Utilized Affymetrix miRNA microarrays to analyze miRNA expression profiles in PD patients and healthy controls.
• Collected samples from PD patients pre- and post-deep brain stimulation (DBS), both during and after electrical stimulation.
• Performed statistical analysis of the expression data using Affymetrix Expression Console software.

Main Results:

• Identified a significant number of differentially expressed miRNAs in Parkinson's disease patients.
• Detected significant alterations in miRNA expression profiles pre- and post-deep brain stimulation (DBS) treatment.
• Observed distinct miRNA expression patterns between PD patients and healthy controls.

Conclusions:

• The study provides evidence for the involvement of specific miRNAs in the pathophysiology of Parkinson's disease.
• Altered miRNA expression levels suggest their potential utility as blood-based biomarkers for PD diagnosis and monitoring.
• Future research should involve larger sample sizes and RNA sequencing for comprehensive miRNA quantification in PD.